Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
Janssen Research & Development, LLC
Ronald F van Vollenhoven; Bevra H Hahn; George C Tsokos; Carrie L Wagner; Peter Lipsky; Zahi Touma; Victoria P Werth; Robert M Gordon; Bei Zhou; Benjamin Hsu; Marc Chevrier; Manon Triebel; Jarrat L Jordan; Shawn Rose